Cardiovascular devices are designed to diagnose, prevent, monitor and treat diseases related to the cardiovascular system, including heart diseases and related health problems. They include arrhythmia detectors, noninvasive blood pressure measurement systems, diagnostic intravascular catheters, external cardiac compressors, coronary vascular physiologic simulation software devices, external programmable pacemaker pulse generators, cardiac monitors, cardiopulmonary bypass defoamers, echocardiographs, vascular graft prostheses, electrocardiographs, defibrillators and others.
The top five companies covered are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health, Inc. and Edwards Lifesciences. Medtronic was the largest company in the cardiovascular devices market in 2017.
The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.
The global cardiovascular devices market was valued at over $55 billion in 2017. Asia Pacific was the largest region in the cardiovascular devices market in 2017, accounting for more than 30% market share. The USA was the largest country in the market in 2017, accounting for more than 20% market share.
Demand for minimally-invasive cardiac surgeries is increasing as they are less disruptive and traumatic for the human body, and result in less post-surgical recovery time and improved efficiency. These techniques may be suitable for certain procedures involving the heart valves and certain types of routine bypass surgeries. For instance, robot assisted heart surgeries are more evident in mitral valve surgeries and heart surgeries. These surgeries are replacing traditional methods with larger incisions. In this procedure surgeons use a computer enhanced device to guide the surgical tools, which consist of robotically-guided arms that reach and operate in difficult-to-reach areas, and a robotically controlled 3D camera for visualization.